Log in

Epigral

NSE: EPIGRAL · ISIN INE071N01016 · Basic Materials

₹898.20−14.95 (−1.64%)

Monday 9 November, 13:31 IST. Delayed. Source: Yahoo Finance.

Price chart

₹898.20 −14.95 (−1.64%) today

The day

Previous close
₹913.15
Open
₹923.00
Day high
₹924.65
Day low
₹894.90

Listed on NSE since 18 August 2021.

Key numbers

Market value
₹3,874.95 Cr
P/E (trailing)
13.60
EPS (trailing)
₹66.03
Price to book
1.64
Dividend yield
0.55%
Return on equity
12.8%
Debt to equity
0.24
Profit margin
10.2%
Beta
0.30
Volume today
38,284
Average volume
58,278

Source: Yahoo Finance. Ratios use the latest reported (trailing twelve-month) figures.

Revenue and profit

Annual revenue and profit
YearRevenueNet profitEPS
FY23₹2,169.44 Cr₹353.29 Cr₹85.03
FY24₹1,893.83 Cr₹195.87 Cr₹47.14
FY25₹2,514.40 Cr₹357.69 Cr₹84.68
FY26₹2,495.48 Cr₹331.97 Cr₹76.95

Source: Yahoo Finance, from annual reports. Consolidated where reported.

Quarterly results

Results for each quarter, latest first
QuarterRevenueNet profitEPSProfit vs year ago
Q2 FY27Jul–Sep 2026₹746 Cr₹65 Cr₹15.09+27.1%
Q1 FY27Apr–Jun 2026₹705 Cr₹100 Cr₹23.12−37.9%
Q4 FY26Jan–Mar 2026Audited₹736 Cr₹81 Cr₹18.76−6.8%
Q3 FY26Oct–Dec 2025₹597 Cr₹39 Cr₹9.07–
Q2 FY26Jul–Sep 2025₹587 Cr₹51 Cr₹11.87–
Q1 FY26Apr–Jun 2025₹607 Cr₹161 Cr₹37.25–

Source: Epigral’s results filed with NSE, consolidated (the whole group). Net profit is the share of Epigral’s own shareholders where the filing separates it. Profit vs year ago compares with the same quarter a year earlier; – where that quarter is not on file or made a loss.

Download results (zip) A spreadsheet of the quarterly results and balance sheets, with the original filings from NSE.

Balance sheet

What the company owns and owes, latest first
As onSeptember 2026March 2026September 2025
Fixed assets₹2,545 Cr₹2,553 Cr₹2,468 Cr
Investments₹0₹0₹21 Cr
Inventories₹365 Cr₹349 Cr₹344 Cr
Owed by customers₹396 Cr₹417 Cr₹227 Cr
Cash and equivalents₹86.00 L₹5 Cr₹15 Cr
Total assets₹3,585 Cr₹3,505 Cr₹3,236 Cr
Borrowings₹565 Cr₹563 Cr₹532 Cr
Total liabilities₹1,221 Cr₹1,284 Cr₹1,135 Cr
Shareholders’ equity₹2,365 Cr₹2,221 Cr₹2,101 Cr

Source: Epigral’s half-yearly statements of assets and liabilities filed with NSE, consolidated. Companies file these every September and March.

About Epigral

Epigral Limited manufactures and sells chlor-alkali and derivative products in India and internationally. The company offers chlorinated polyvinyl chloride (CPVC) resin, epichlorohydrin, chloromethanes value chain, hydrogen peroxide, caustic soda and potash, chlorine, hydrogen, chloromethanes, captive power plant (CPP), and chlorotoluene value chain, as well as operates wind-solar hybrid power plant. Its products are used in CPVC pipes and fittings, windmills, construction, paints and coatings, electronics, water treatment, agrochemicals, pharmaceuticals, refineries, soap and detergents, fluoropolymers, paper and pulp, textiles, alumina, polyurethane foam, lithium, and polytetrafluoroethylene (PTFE) pipes. The company was formerly known as Meghmani Finechem Limited and changed its name to Epigral Limited in August 2023. Epigral Limited was incorporated in 2007 and is based in Ahmedabad, India.

Industry
Chemicals
Based in
Ahmedabad
Employees
1,135

Company website · Profile: Yahoo Finance

In the news

All news

No headlines name Epigral in the last day or two.

Dividends and corporate actions

All companies
  • Dividend - Rs 5 Per Share

    Dividend · ex-date 1 June 2026

  • Dividend - Rs 3.50 Per Share

    Dividend · ex-date 20 June 2025 · record date 21 June 2025

  • Interim Dividend - Rs 2.50 Per Share

    Dividend · ex-date 7 February 2025

  • Annual General Meeting/Dividend - Rs 5 Per Share

    Dividend · ex-date 2 July 2024

  • Annual General Meeting

    Action · ex-date 20 June 2023

  • Dividend - Rs 2.50 Per Share

    Dividend · ex-date 20 June 2023

  • Interim Dividend - Rs 2.50 Per Share

    Dividend · ex-date 1 February 2023

  • Annual General Meeting

    Action · ex-date 17 June 2022

Source: NSE. Latest first, 8 of 9.

Information only, not investment advice. Prices are delayed.

ShareWhatsAppTelegram

Open inZerodha ↗Groww ↗Angel One ↗For convenience only: no referral, not a recommendation.